Updated Results from a Phase I/II Study of the Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with <i>FLT3</i>-Mutated Acute Myeloid Leukemia

Nicholas J. Short, Courtney D. DiNardo, Naval Daver, Walid Macaron, Musa Yılmaz, Gautam Borthakur, Guillermo Montalban‐Bravo, Guillermo Garcia‐Manero, Ghayas C. Issa, Koji Sasaki, Philip A. Thompson, Jan A. Burger, Abhishek Maiti, Yesid Alvarado, Monica Kwari, Ricardo Delumpa, Jennifer Thankachan, Ejiroghene Mayor, Christopher Loiselle, Anna Milton, Glenda Banks, Tapan M. Kadia, Marina Konopleva, Hagop M. Kantarjian, Farhad Ravandi